Patents by Inventor Brian James Robbins

Brian James Robbins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Orally administered liquid compositions
    Patent number: 7138133
    Abstract: The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow the active to precipitate or settle out of solution. Among the advantages of this invention is that the compositions do not require agitation/shaking prior to use as a method to re-suspend or dissolve active drug material to insure even and consistent dosing.
    Type: Grant
    Filed: October 10, 2001
    Date of Patent: November 21, 2006
    Assignee: The Procter & Gamble Company
    Inventors: Douglas Joseph Dobrozsi, Jerry William Hayes, II, Francis Joseph David Bealin-Kelly, Jayant Eknath Khanolkar, Benoit Maurice Mullet, Shane Michael DE LA Harpe, Brian James Robbins
  • Compositions having improved delivery of actives
    Patent number: 6846495
    Abstract: The present invention pertains to compositions having improved delivery of pharmaceutical actives. These compositions comprise pharmaceutical actives in an anhydrous solvent. These compositions may take the form of liquid elixirs placed into the mouth and eventually swallowed, or can be delivered via liquid-filled drops, metered liquid dosing devices, atomizers and liquid-releasing, edible capsules.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: January 25, 2005
    Assignee: The Procter & Gamble Company
    Inventors: Douglas Joseph Dobrozsi, Jerry William Hayes, II, Kishor Jivanlal Desai, Brian James Robbins
  • Orally administered liquid compositions
    Publication number: 20030113377
    Abstract: The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow the active to precipitate or settle out of solution.
    Type: Application
    Filed: October 10, 2001
    Publication date: June 19, 2003
    Inventors: Douglas Joseph Dobrozsi, Jerry William Hayes, Francis Joseph David Bealin-Kelly, Jayant Eknath khanolkar, Benoit Maurice Mullet, Shane Michael Dela Harpe, Brian James Robbins